Matthew Nielsen | |
---|---|
Academic background | |
Education | MD, 2002, Johns Hopkins University MS, Clinical Research, 2012, University of North Carolina at Chapel Hill |
Academic work | |
Institutions | UNC School of Medicine |
Matthew E. Nielsen is an American urologist oncologist and health services researcher. He is a Full professor and Chair of Urology at the UNC School of Medicine. Nielsen joined the faculty at UNC in 2009 as a urologic oncologist and health services researcher after completing medical school and residency training at Johns Hopkins.
Nielsen earned his medical degree from Johns Hopkins University where he stayed to complete his residency in general surgery and urology. From there,he completed his Master's degree in Clinical Research at the University of North Carolina at Chapel Hill in 2012. [1]
Nielsen joined the faculty at the UNC School of Medicine in 2009 as a urologic oncologist and health services researcher after completing his residency training at Johns Hopkins. [2] [3] In this role,he was selected as a Clinical Research Scholar on the UNC Clinical Translation Science Award –K12 Scholars Program to "transform how clinical and translation research is conducted." [4] He was later selected as one of two recipients of the three-year,$101,000 2013 Urology Care Foundation/Astellas Rising Stars in Urology Research Award. [5]
As an associate professor and Director of Urologic Oncology,Nielsen was appointed by the Council of Medical Specialty Societies (CMSS) Board of Directors as the CMSS Representative to the Physician Consortium for Performance Improvement. [6] The following year,he was the lead author on a report from the American College of Physicians’High Value Care Task Force which questioned the potential harms associated with diagnostic tests but also acknowledged that blood in the urine may be the only warning sign of cancer in the urinary tract of some patients. [7] Nielsen was later named co-director of Cross-Institutional Quality Improvement Implementation efforts with the High Value Practice Academic Alliance (HVPAA). [8]
During the COVID-19 pandemic in North America,Nielsen was appointed to the Centers for Medicare and Medicaid Services Technical Expert Panel to identify,analyze,and prioritize measurement gaps for the 2020 Quality Measure Development Plan Annual Report. [9] He was also appointed Interim Chair of the Department of Urology [10] and promoted to the position of Professor with Tenure. [11] While serving in this role,he collaborated with Lixin Song to use wearable technology to help bladder and colorectal cancer patients catch and address post-surgical symptoms and complications before they require more intensive medical care. [12] In November,Nielsen was included in Castle Connolly Medical Ltd's 2020 Listing of Top Doctors [13] and appointed Chair of the Department of Urology. [14]
Urology,also known as genitourinary surgery,is the branch of medicine that focuses on surgical and medical diseases of the urinary-tract system and the reproductive organs. Organs under the domain of urology include the kidneys,adrenal glands,ureters,urinary bladder,urethra,and the male reproductive organs.
Nicholas J. Vogelzang was a medical oncologist with Comprehensive Cancer Centers of Nevada (CCCN). He serves as medical director of the Research Executive Committee and Associate Chair of the Developmental Therapeutics and Genitourinary Committees for US Oncology Research. His research interests include clinical trials for genitourinary malignancies and mesothelioma.
The University of California,Los Angeles School of Medicine,also known as the David Geffen School of Medicine at UCLA (DGSOM),is an accredited medical school located in Los Angeles,California,United States. Founded in 1951,it is the second medical school in the University of California system,after the UCSF School of Medicine. The school was renamed in 2001 in honor of media mogul David Geffen who donated $200 million in unrestricted funds.
Ashutosh K. Tewari is the chairman of urology at the Icahn School of Medicine at Mount Sinai Hospital in New York City. He is a board certified American urologist,oncologist,and principal investigator. Before moving to the Icahn School of Medicine in 2013,he was the founding director of both the Center for Prostate Cancer at Weill Cornell Medical College and the LeFrak Center for Robotic Surgery at NewYork–Presbyterian Hospital. Dr. Tewari was the Ronald P. Lynch endowed Chair of Urologic Oncology and the hospital's Director of Robotic Prostatectomy,treating patients with prostate,urinary bladder and other urological cancers. He is the current President of the Society for Urologic Robotic Surgeons (SURS) and the Committee Chair of the Prostate Program. Dr. Tewari is a world leading urological surgeon,and has performed over 10,000 robotically assisted procedures using the da Vinci Surgical System. Academically,he is recognized as a world-renowned expert on urologic oncology with over 250 peer reviewed published papers to his credit;he is on such lists as America's Top Doctors,New York Magazine's Best Doctors,and Who's Who in the World. In 2012,he was given the American Urological Association Gold Cystoscope Award for "outstanding contributions to the field of urologic oncology,most notably the treatment of prostate cancer and the development of novel techniques to improve the outcomes of robotic prostatectomy."
Johannes W. Vieweg is an American medical school dean,university professor,and physician-scientist,presently residing in the city of Fort Lauderdale,Florida.
Richard Trevor Turner-Warwick was a British urologist who was internationally known for his work on the surgical restoration of the structure and function of the genitourinary tract. He introduced video-cysto-urethrography.
Mark S. Soloway is a leading authority in urologic cancer,researcher,former departmental chair,medical professor and invitational lecturer. He served as chairman of the University of Miami Miller School of Medicine Department of Urology and is currently a professor at the Miller School of Medicine. Born in Cleveland,Soloway received his B.Sc. from Northwestern University in Chicago (1961–1964). He completed his M.D. and residency at Case Western Reserve University School of Medicine in Cleveland,Ohio (1964–1970). He completed a fellowship at the National Cancer Institute of the National Institute of Health in Bethesda,MD (1970–1972). Soloway has received numerous awards for his work as a researcher and teacher,These awards are American Urological Association's Gold Cystoscope award,Mosby Scholarship for Scholastic Excellence award (1967),North Central Section of American Urological Association Traveling Fellowship award (1972) and many others. These are outstanding achievements for an individual who has contributed most to the field of urology within ten years of completion of his residency program”(1984).
Peter T. Scardino is an American cancer surgeon,researcher,and author expert in genitourinary and urological cancers particularly cancer of the prostate. He is chair of the Department of Surgery at Memorial Sloan Kettering Cancer Center.
William D. Steers was a Paul Mellon professor and chair of the Department of Urology at the University of Virginia School of Medicine. He was a president of the American Board of Urology (ABU) and editor of The Journal of Urology. In 2003,the University of Virginia awarded Steers the Hovey Dabney Professorship. In 2004,Dr. Steers initiated the Charlottesville Men's Four Miler road race to raise funds for men's health. Steers was a viticulturist,and co-owned Well Hung Vineyard in Charlottesville. He developed YOURometer,an iPhone app used to record urological related symptoms.
Arie S. Belldegrun,FACS,is an Israeli-American urologic oncologist,billionaire businessman and investor.
J. Kellogg Parsons is an American physician specializing in urology.
Dipen J. Parekh is Chief Operating Officer at the University of Miami Health System,Chairman of Urology and the Dr. Victor Politano Endowed Chair in Clinical Urology at the Miller School of Medicine at University of Miami in Miami. He also serves as the Director of Robotic surgery at the University of Miami Health System. In 2012,he was awarded the American Urological Association Gold Cystoscope Award for his excellence in "establishing programs in urologic oncology and robotic surgery and outstanding contributions in transformative research".
Kurt McCammon is a Professor and the Devine Chair in Genitourinary Reconstructive Surgery at Eastern Virginia Medical School,where he has served as the Chairman for the Department of Urology since 2011,Program Director of the Department of Urology since 2006,and Fellowship Director for the Adult and Pediatric Genitourinary Reconstructive Surgery since 2010. Additionally,he is the past president of the Society of Genitourinary Reconstructive Surgeons,on the board of the International Volunteers in Urology,and a current member of the American Urological Association Board of Directors. As a reconstructive urologist,McCammon surgically addresses urethral stricture disease,male urinary incontinence,erectile dysfunction,female urinary incontinence,genital abnormalities,and other genitourinary issues.
David "Neil" Hayes is an American oncologist and physician–scientist. He is the Van Vleet Endowed Professor in Medical Oncology and the division chief of haematology and oncology at the University of Tennessee Health Science Center. As a result of his research,Hayes was elected a Member of the American Society for Clinical Investigation.
Melina R. Kibbe is an American clinician and researcher in the field of vascular surgery. She currently serves as Dean of the University of Virginia School of Medicine. She previously held the Colin G. Thomas Jr. Distinguished Professorship and Chair of the Department of Surgery at UNC School of Medicine.
Reshma Jagsi is an American Radiation oncologist. She is the Lawrence W. Davis Professor and Chair in the Department of Radiation Oncology and Senior Faculty Fellow in the Center for Ethics at Emory University. Overall,she is the author of over 450 published articles in peer-reviewed medical journals and continues scholarly research in three primary areas of interest:breast cancer,bioethics,and gender equity,with the support of grants from the National Institutes of Health (NIH),the Doris Duke Charitable Foundation,and the Susan G. Komen Foundation,for which she serves as a Senior Scholar.
Benjamin N. Breyer is an American urologic surgeon. As a Professor of Urology,Epidemiology,and Biostatistics at the University of California,San Francisco,he specializes in complex urethral and penile reconstruction,male incontinence,male fistula,surgical treatment for erectile dysfunction.
Gustavo S. Oderich is a Brazilian American vascular and endovascular surgeon who serves as a professor and chief of vascular and endovascular surgery,and is the director of the Advanced Endovascular Aortic Program at McGovern Medical School at The University of Texas Health Science Center at Houston and Memorial Hermann Health System. He previously served as chair of vascular and endovascular division at the Mayo Clinic in Rochester,Minnesota. Oderich is recognized for his work in minimally invasive endovascular surgery and research in fenestrated and branched stent-graft technology to treat complex aortic aneurysms and dissections.
Elizabeth R. Plimack is an American medical oncologist. She is a professor in the Department of Hematology/Oncology and Chief of the Division of Genitourinary Medical Oncology at the Fox Chase Cancer Center. In these roles,she researches the treatment of genitourinary malignancies with a focus on bladder and kidney cancers.
W. Kimryn Rathmell is an American physician-scientist whose work focuses on the research and treatment of patients with kidney cancers. She is the Hugh Jackson Morgan Professor and Chair of the Department of Medicine at Vanderbilt University Medical Center (VUMC),and Physician-in-Chief for Vanderbilt University Adult Hospital and Clinics in Nashville,Tennessee. On Nov. 17,2023,Rathmell was announced as the next Director of the National Cancer Institute.